Immuneering Corp (IMRX) Social Stream
IMMUNEERING CORP (IMRX) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering IMRX.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-09 | 4 | $50 | $39 | $43.666 | $6.23 | 600.9% |
| 2021-12-22 | 5 | $42 | $35 | $38.666 | $6.23 | 520.64% |
| 2022-01-07 | 5 | $42 | $35 | $39.25 | $6.23 | 530.02% |
| 2022-03-10 | 5 | $42 | $18 | $34 | $6.23 | 445.75% |
| 2022-03-27 | 5 | $42 | $18 | $30.25 | $6.23 | 385.55% |
| 2022-05-10 | 6 | $42 | $18 | $29.2 | $6.23 | 368.7% |
| 2022-05-11 | 6 | $42 | $16 | $28.4 | $6.23 | 355.86% |
| 2022-07-25 | 7 | $42 | $12 | $25.666 | $6.23 | 311.97% |
| 2022-08-11 | 7 | $42 | $12 | $25.333 | $6.23 | 306.63% |
| 2022-09-30 | 6 | $41 | $12 | $22 | $6.23 | 253.13% |
| 2022-12-20 | 6 | $41 | $12 | $22.4 | $6.23 | 259.55% |
| 2023-03-07 | 7 | $41 | $5 | $21 | $6.23 | 237.08% |
| 2023-04-12 | 7 | $41 | $5 | $19.166 | $6.23 | 207.64% |
| 2023-04-18 | 7 | $41 | $5 | $19.166 | $6.23 | 207.64% |
| 2023-05-05 | 7 | $41 | $14 | $23 | $6.23 | 269.18% |
| 2023-11-10 | 7 | $25 | $14 | $19.833 | $6.23 | 218.35% |
| 2023-12-04 | 7 | $25 | $14 | $19.666 | $6.23 | 215.67% |
| 2023-12-19 | 8 | $25 | $10 | $19.142 | $6.23 | 207.26% |
The Trend in the Analyst Price Target
Over the past 20 months, IMRX's average price target has gone down $9.4.
Over the past 46 weeks, IMRX's average upside potential has been 186.13%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-07 | 6 | 41 | 5 | 21.000 | 5.51 | 281.13% |
| 2023-04-05 | 7 | 41 | 5 | 19.166 | 8.36 | 129.26% |
| 2023-04-18 | 7 | 41 | 5 | 19.166 | 13.36 | 43.46% |
| 2023-10-13 | 7 | 25 | 14 | 19.833 | 6.00 | 230.55% |
| 2023-12-19 | 7 | 25 | 10 | 19.000 | 7.78 | 144.22% |
IMRX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.38 | 6 | 1 | 1 | 0 | 0 | 8 |
The Trend in the Broker Recommendations
Over the past 31 weeks, IMRX's average broker recommendation rating improved by 0.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of all US stocks, IMMUNEERING CORP's upside potential (average analyst target price relative to current price) is higher than 1995.19% of them.
- IMMUNEERING CORP's variance in analysts' estimates is lower than -1519.65% of all US stocks.
- To contextualize these metrics, consider that out of stocks in the small market cap category, IMMUNEERING CORP's number of analysts covering the stock is higher than 1545.88% of them.
- To contextualize these metrics, consider that out of stocks in the small market cap category, IMMUNEERING CORP's average analyst price target is higher than 1450.56% of them.
Stocks similar to IMMUNEERING CORP in the Pharmaceutical Products industry regarding analyst recommendations and price targets are RANI, CYBN, and ELYM.
View All Top Stocks by Price Target
Is IMRX a Buy, Hold or Sell? See the POWR Ratings now!